These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
74 related articles for article (PubMed ID: 2856270)
1. Angiotensin-converting enzyme inhibition or aldosterone antagonism reduces cyclosporine nephrotoxicity in the rat. Thomson AW; McAuley FT; Whiting PH; Simpson JG Transplant Proc; 1987 Feb; 19(1 Pt 2):1242-3. PubMed ID: 2856270 [No Abstract] [Full Text] [Related]
2. The influence of enalapril or spironolactone on experimental cyclosporin nephrotoxicity. McAuley FT; Whiting PH; Thomson AW; Simpson JG Biochem Pharmacol; 1987 Mar; 36(5):699-703. PubMed ID: 3030332 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporine related hypertension and nephrotoxicity in rat heart transplantation. Kanehira A; Shida T; Nakamura H; Wakita N; Ito H; Nakamura K Dev Toxicol Environ Sci; 1986; 14():141-7. PubMed ID: 3549246 [No Abstract] [Full Text] [Related]
4. A dynamic comparative study concerning the effects of angiotensin-converting enzyme inhibitors and aldosterone receptor blockers on the fibrinolytic system. Usalan C; Buyukhatipoglu H Clin Appl Thromb Hemost; 2008 Apr; 14(2):203-9. PubMed ID: 18372278 [TBL] [Abstract][Full Text] [Related]
5. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats. Taira M; Toba H; Murakami M; Iga I; Serizawa R; Murata S; Kobara M; Nakata T Eur J Pharmacol; 2008 Jul; 589(1-3):264-71. PubMed ID: 18582458 [TBL] [Abstract][Full Text] [Related]
6. The effect of calcium blockade with verapamil on experimental cyclosporine nephrotoxicity. Orugun EO; Smart LM; Whiting PH Transplant Proc; 1991 Feb; 23(1 Pt 1):354-5. PubMed ID: 1990550 [No Abstract] [Full Text] [Related]
7. Nephrotoxicity of cyclosporine G and A in the Sprague-Dawley rat. Duncan JI; Simpson JG; Thomson AW; Whiting PH Transplant Proc; 1987 Feb; 19(1 Pt 2):1391-2. PubMed ID: 3274338 [No Abstract] [Full Text] [Related]
8. Spironolactone and enalapril differentially up-regulate the expression of VEGF and heme oxygenase-1 in the neonatal rat kidney. Yim HE; Kim JH; Yoo KH; Bae IS; Hong YS; Lee JW Pediatr Res; 2011 May; 69(5 Pt 1):378-83. PubMed ID: 21263376 [TBL] [Abstract][Full Text] [Related]
9. The effects of converting enzyme inhibitors on plasma angiotensinogen and plasma aldosterone in sodium-depleted rats. Clauser E; Gonzalez MF; Bouhnik J; Corvol P; Ménard J J Hypertens Suppl; 1983 Oct; 1(1):37-40. PubMed ID: 6100608 [TBL] [Abstract][Full Text] [Related]
11. Renal haemodynamics and function in weanling rats treated with enalapril from birth. Guron G Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):865-70. PubMed ID: 16173949 [TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
13. Acute cyclosporine A nephrotoxicity in rats: which role for renin-angiotensin system and glomerular prostaglandins? Perico N; Benigni A; Bosco E; Rossini M; Orisio S; Ghilardi F; Piccinelli A; Remuzzi G Clin Nephrol; 1986; 25 Suppl 1():S83-8. PubMed ID: 3519031 [TBL] [Abstract][Full Text] [Related]
14. Reduction of cyclosporin (CSA) nephrotoxicity by imipenem/cilastatin after kidney transplantation in rats. Hammer C; Thies JC; Mraz W; Mihatsch M Transplant Proc; 1989 Feb; 21(1 Pt 1):931. PubMed ID: 2650296 [No Abstract] [Full Text] [Related]
15. Nuclear magnetic resonance and biochemical studies to determine the synergistic detrimental effects of renal ischemia on cyclosporine nephrotoxicity in the rat. Chan L; Suleymanlar G; Malhotra D; Lien YH; Shapiro JI Transplant Proc; 1991 Feb; 23(1 Pt 1):711-3. PubMed ID: 1990660 [No Abstract] [Full Text] [Related]
16. Studies on nephrotoxicity of cyclosporine in human renal allograft and rat. Morozumi K; Shinmura I; Gotoh I; Yoshida A; Fujinami T; Uchida K; Yamada N; Tominaga Y; Nakanishi Y; Kanoh T Dev Toxicol Environ Sci; 1986; 14():153-6. PubMed ID: 3549247 [No Abstract] [Full Text] [Related]
17. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system]. Jover B; Dupont M; Casellas D; Mimran A Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235 [TBL] [Abstract][Full Text] [Related]
18. Effect of spironolactone on the renin-aldosterone system in rats. Jiménez W; Martínez-Pardo A; Arroyo V; Gaya J; Rivera F Rev Esp Fisiol; 1988 Sep; 44(3):257-63. PubMed ID: 3068736 [TBL] [Abstract][Full Text] [Related]
19. Effect of enalapril on renin, angiotensin converting enzyme activity, aldosterone and prostaglandins in patients with hypertension. Larochelle P; Gutkowska J; Schiffrin E; Kuchel O; Hamet P; Genest J Clin Invest Med; 1985; 8(3):197-201. PubMed ID: 2994932 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation. Wilkes BM J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]